Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,349,552
+$509,809 QoQ
Shares Held
30,168
-7.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 299 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$1,225,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. RYTM ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in RYTM
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,349,552 | 30,168 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,839,743 | 32,652 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,356,346 | 31,356 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $362,049 | 3,585 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,534,126 | 24,278 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,442,540 | 83,869 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,698,124 | 48,198 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $224,962 | 4,294 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $453,318 | 10,462 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,906,777 | 128,492 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $4,963,141 | 278,203 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,353,033 | 355,530 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,485,190 | 183,069 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $1,225,000 | 50,000 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $151,441 | 36,492 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,117,267 | 96,985 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $673,259 | 31,653 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||